Kymera Therapeutics, Inc.
KYMR
$81.21
$1.612.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 848.28M | 505.68M | 665.45M | 463.15M | 488.74M |
| Total Receivables | -- | -- | 40.00M | 20.00M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.94M | 22.62M | 22.88M | 17.80M | 21.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 871.21M | 528.30M | 728.33M | 500.95M | 510.27M |
|
|
|||||
| Total Current Assets | 871.21M | 528.30M | 728.33M | 500.95M | 510.27M |
| Net Property, Plant & Equipment | 85.53M | 88.08M | 94.62M | 95.91M | 97.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.91M | 12.62M | 10.50M | 9.12M | 7.74M |
| Total Assets | 1.74B | 1.10B | 1.13B | 918.31M | 978.04M |
|
|
|||||
| Total Accounts Payable | 4.02M | 5.51M | 5.78M | 10.26M | 5.99M |
| Total Accrued Expenses | 42.27M | 28.64M | 27.98M | 23.12M | 34.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.76M | 13.74M | 13.67M | 13.24M | 13.11M |
| Total Finance Division Other Current Liabilities | 23.17M | 23.69M | 40.12M | 12.37M | 13.80M |
| Total Other Current Liabilities | 23.17M | 23.69M | 40.12M | 12.37M | 13.80M |
| Total Current Liabilities | 83.21M | 71.58M | 87.54M | 58.99M | 67.77M |
|
|
|||||
| Total Current Liabilities | 83.21M | 71.58M | 87.54M | 58.99M | 67.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 68.50M | 70.25M | 72.05M | 73.09M | 74.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.44M | 13.96M | -- | -- | -- |
| Total Liabilities | 163.15M | 155.79M | 159.59M | 132.08M | 142.42M |
|
|
|||||
| Common Stock & APIC | 2.64B | 1.92B | 1.87B | 1.61B | 1.59B |
| Retained Earnings | -1.07B | -978.98M | -896.81M | -820.19M | -754.61M |
| Treasury Stock & Other | 1.80M | 1.50M | 279.00K | -58.00K | -1.49M |
| Total Common Equity | 1.58B | 946.26M | 971.48M | 786.23M | 835.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.58B | 946.26M | 971.48M | 786.23M | 835.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.58B | 946.26M | 971.48M | 786.23M | 835.62M |
|
|
|||||